GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could spare stomach cancer patients from unnecessary chemo
Disease control Not yet recruitingThis study is testing a new approach for treating stomach cancer. After surgery, a blood test will check for tiny traces of leftover cancer. The goal is to see if patients with a clean blood test can safely skip the usual harsh chemotherapy, avoiding its severe side effects, with…
Matched conditions: GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Real-World trial tests best drug combo to keep stomach cancer from returning
Disease control Not yet recruitingThis study aims to find the best drug combination to prevent stomach cancer from returning after successful surgery. It will compare two different drug regimens in 500 patients who had their cancer completely removed. The goal is to see which treatment keeps patients cancer-free …
Matched conditions: GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE4 • Sponsor: Liaoning Cancer Hospital & Institute • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for shrinking tough stomach tumors before surgery
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called zanidatamab to standard chemotherapy can better shrink tumors before surgery in people with locally advanced HER2-positive stomach or gastroesophageal junction cancer. The goal is to see if this combination leads to…
Matched conditions: GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo trial targets four tough digestive cancers
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called SSGJ-706 to standard first-line chemotherapy can better control advanced cancers of the stomach, colon, pancreas, and esophagus. It will enroll about 300 adults with these cancers who have not yet received treatment…
Matched conditions: GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo targets tough cancers in major trial
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called IBI343 to other treatments is safe and effective for people with advanced stomach or pancreatic cancer that has a specific marker called CLDN18.2. About 389 participants will receive the combination therapy to see i…
Matched conditions: GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists hunt clues to unlock stomach Cancer's immune resistance
Disease control Not yet recruitingThis study aims to understand why some patients with a specific type of stomach cancer respond well to immunotherapy while others do not. It will enroll 15 Asian patients with this cancer type who are scheduled for surgery after receiving immunotherapy. The goal is to learn what …
Matched conditions: GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New stomach cancer treatment trial tests easier injection method
Disease control Not yet recruitingThis study is testing whether giving the immunotherapy drug AK104 as a simple injection under the skin works as well as giving it through an IV when combined with standard chemotherapy for advanced stomach cancer. The trial will enroll 422 people with advanced stomach or gastroes…
Matched conditions: GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Akeso • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC